Holen Sie sich die Stockscreener-App
1.39
9.45%
0.12
Handel nachbörslich:
1.43
0.04
+2.88%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HRTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$1.27
Offen:
$1.28
24-Stunden-Volumen:
7.29M
Relative Volume:
3.79
Marktkapitalisierung:
$254.87M
Einnahmen:
$137.74M
Nettoeinkommen (Verlust:
$-27.97M
KGV:
-8.6875
EPS:
-0.16
Netto-Cashflow:
$-9.61M
1W Leistung:
+10.32%
1M Leistung:
+4.51%
6M Leistung:
-37.67%
1J Leistung:
-13.13%
1-Tages-Spanne:
$1.28
$1.575
1-Wochen-Bereich:
$1.18
$1.575
52-Wochen-Spanne:
$0.9999
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Firmenname
Heron Therapeutics Inc
Sektor
Branche
Telefon
(858) 251-4400
Adresse
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Vergleichen Sie HRTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.39 | 232.87M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-09 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-06-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-04-23 | Eingeleitet | CapitalOne | Overweight |
| 2024-03-13 | Bestätigt | Needham | Buy |
| 2020-05-27 | Eingeleitet | Guggenheim | Buy |
| 2020-02-20 | Bestätigt | Needham | Buy |
| 2019-01-16 | Bestätigt | Needham | Buy |
| 2018-04-05 | Eingeleitet | Evercore ISI | Outperform |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2018-03-01 | Bestätigt | Needham | Buy |
| 2018-01-03 | Eingeleitet | Leerink Partners | Outperform |
| 2017-09-27 | Eingeleitet | Northland Capital | Outperform |
| 2017-02-27 | Eingeleitet | Needham | Buy |
| 2016-10-26 | Eingeleitet | Aegis Capital | Buy |
| 2016-09-06 | Fortgesetzt | Lake Street | Buy |
| 2016-05-03 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-12-10 | Eingeleitet | Lake Street | Buy |
| 2015-09-23 | Bestätigt | Leerink Partners | Outperform |
| 2015-09-02 | Eingeleitet | BofA/Merrill | Buy |
| 2015-08-03 | Bestätigt | Brean Capital | Buy |
| 2015-06-30 | Bestätigt | JMP Securities | Mkt Outperform |
| 2015-06-19 | Bestätigt | Leerink Partners | Outperform |
| 2014-08-07 | Eingeleitet | Noble Financial | Buy |
Alle ansehen
Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten
Heron Therapeutics Expands Strategic Vision Amid Market Fluctuations - StocksToTrade
Heron Therapeutics Reports Strong Preliminary Q4 2025 Revenue - TipRanks
Heron Therapeutics' (HRTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Heron Therapeutics stock soars after strong Q4 revenue growth By Investing.com - Investing.com Canada
Heron rises as revenue figures exceed estimates (HRTX:NASDAQ) - Seeking Alpha
Heron Therapeutics announces preliminary, unaudited Q4 results - MarketScreener
Heron Therapeutics Reports Preliminary Fourth Quarter and Full-Year 2025 Financial Results - Quiver Quantitative
Heron Therapeutics Announces Preliminary, Unaudited Q4 and - GlobeNewswire
Will Heron Therapeutics Inc. stock gain from strong economy2025 Key Lessons & Long-Term Growth Stock Strategies - ulpravda.ru
Does Heron Therapeutics Inc. stock trade at a discount to peers2025 Bull vs Bear & High Yield Stock Recommendations - ulpravda.ru
How analysts rate Heron Therapeutics Inc. stock todayWeekly Gains Summary & Verified Momentum Stock Alerts - ulpravda.ru
Will Heron Therapeutics Inc. stock maintain dividend yield2025 Volatility Report & Long Hold Capital Preservation Tips - ulpravda.ru
Can Heron Therapeutics Inc. stock sustain market leadershipIndustrial Stocks Review & High Profit Growth Stocks - ulpravda.ru
Will Heron Therapeutics Inc. stock outperform tech sector in 20252026 world cup usa national team group stage star players high defensive line tactical prediction insights - ulpravda.ru
Is Heron Therapeutics Inc AXD2 a good long term investmentConsumer Goods Stocks & Small Capital Gains - earlytimes.in
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Exit Recap: Does Heron Therapeutics Inc stock trade at a discount to peers2025 Market WrapUp & Verified Momentum Watchlists - moha.gov.vn
What analysts say about Heron Therapeutics Inc AXD2 stockContrarian Investment Ideas & High Return Investment Growth - earlytimes.in
Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Investor Mood: Will Heron Therapeutics Inc stock outperform tech sector in 2025Bear Alert & Long Hold Capital Preservation Tips - moha.gov.vn
Is Heron Therapeutics Inc. stock attractive for income investorsJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Can Heron Therapeutics Inc. stock surprise with earnings upsideJuly 2025 Spike Watch & Detailed Earnings Play Alerts - Улправда
How Heron Therapeutics Inc. stock reacts to global recession fearsWeekly Trend Recap & Community Consensus Picks - Улправда
How supply chain issues affect Heron Therapeutics Inc. stockJuly 2025 Movers & Daily Volume Surge Trade Alerts - Улправда
Is Heron Therapeutics Inc. stock cheap at current valuationJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - DonanımHaber
Can Heron Therapeutics Inc. stock sustain revenue growthJuly 2025 Review & Growth Focused Stock Reports - Улправда
Is Heron Therapeutics Inc. stock gaining market shareInflation Watch & Community Consensus Trade Alerts - Улправда
Heron Therapeutics Earnings Notes - Trefis
Congress Park Capital LLC Acquires 621,908 Shares of Heron Therapeutics, Inc. $HRTX - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Catapults 27% Though Its Price And Business Still Lag The Industry - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company - Yahoo Finance
Heron Therapeutics Appoints Thomas Cusack to Board - MSN
Heron Therapeutics Reports Strong Q3 2025 Revenue Growth - MSN
Heron Therapeutics Inc (HRTX) can make a big difference with a little luck - setenews.com
Heron Therapeutics Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Heron Therapeutics enters board agreement and completes refinancing transactions By Investing.com - Investing.com Nigeria
Activity Recap: Will Heron Therapeutics Inc stock deliver long term returnsDividend Hike & Weekly Market Pulse Updates - BỘ NỘI VỤ
San Diego Biotech Firm Heron Therapeutics Shifts Operations to North Carolina - MSN
What analysts say about Heron Therapeutics Inc stockGrowth Stock Opportunities & 5 Stocks Every Investor Should Own - earlytimes.in
Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) - simplywall.st
Can Heron Therapeutics Inc. stock sustain institutional interestMarket Trend Report & High Return Trade Guides - Newser
Can Heron Therapeutics Inc. (AXD2) stock expand revenue streamsWeekly Profit Analysis & Fast Entry and Exit Trade Plans - Newser
How cyclical is Heron Therapeutics Inc. (AXD2) stock compared to rivalsJuly 2025 Setups & Fast Entry High Yield Tips - Newser
Heron Therapeutics announces inclusion of Aponvie (aprepitant) - marketscreener.com
Heron Therapeutics Announces Inclusion of APONVIE® - GlobeNewswire
Why Heron Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Report & Detailed Earnings Play Strategies - Newser
HRTXHeron Therapeutics Inc Latest Stock News & Market Updates - Stock Titan
Heron Therapeutics Injects New Life Into Growth Story With ZYNRELEF And APONVIE Momentum - RTTNews
Will Heron Therapeutics Inc. stock deliver long term returnsCPI Data & Risk Controlled Swing Trade Alerts - Newser
History Review: Can Heron Therapeutics Inc. stock sustain market leadershipJuly 2025 WrapUp & Daily Profit Focused Screening - BỘ NỘI VỤ
Finanzdaten der Heron Therapeutics Inc-Aktie (HRTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):